<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="anticancer agents. Such compounds are effective against various types of" exact="cancer" post="cell lines through a multitude of mechanisms, some of"/>
 <result pre="pharmacological profile of the drug used for the management of" exact="amyotrophic lateral sclerosis" post="Riluzole (Figure 1) attracted the attention of medicinal chemists"/>
 <result pre="active benzothiazole5. Figure 1. Structure of riluzole, a drug for" exact="amyotrophic lateral sclerosis." post="The BTA scaffold possesses a wide spectrum of biological"/>
 <result pre="biological and pharmacological activities against different types of tumours and" exact="cancer" post="cell lines such as HeLa (human cervical cancer cell"/>
 <result pre="of tumours and cancer cell lines such as HeLa (human" exact="cervical cancer" post="cell line), SW480 (human colon adenocarcinoma cell line), HepG2"/>
 <result pre="tumours and cancer cell lines such as HeLa (human cervical" exact="cancer" post="cell line), SW480 (human colon adenocarcinoma cell line), HepG2"/>
 <result pre="drugs, medicines and procedures for safer treatment and cure of" exact="cancer" post="disease20. These neoplasm tumour cells are diversified, heterogeneous cells"/>
 <result pre="procedures for safer treatment and cure of cancer disease20. These" exact="neoplasm" post="tumour cells are diversified, heterogeneous cells with rapid proliferative"/>
 <result pre="cells are diversified, heterogeneous cells with rapid proliferative properties. These" exact="neoplasm" post="malignant tumours, have potential to invade or spread to"/>
 <result pre="drug discovery and drug development for the treatment of lethal" exact="cancer" post="disease. 2. BTA derivatives as anticancer agents 2.1. Fluorinated"/>
 <result pre="2-aryl benzothiazole derivatives and evaluate them for anti-tumour activities against" exact="cancer" post="cell lines such as MDA-MB-468 (mammary gland/breast tissues derived"/>
 <result pre="in the levels of caspase-3. The compound 4 exhibited anti" exact="cancer" post="activity and proved to be the best antiproliferative agent"/>
 <result pre="compound 4 have potential to lead in the treatment of" exact="cancer" post="especially against hepatocaricinoma. The anticancer activity potential of BTA"/>
 <result pre="benzothiazole core and these scaffolds were screened against 60 human" exact="cancer" post="cell lines. The urea moiety based fluorophenyl containing benzothiazole"/>
 <result pre="âˆ’5.48), non-small cell lung cell lines (log GI50 value âˆ’5.48)," exact="colon cancer" post="cell lines (log GI50 value âˆ’5.51), central nervous system"/>
 <result pre="non-small cell lung cell lines (log GI50 value âˆ’5.48), colon" exact="cancer" post="cell lines (log GI50 value âˆ’5.51), central nervous system"/>
 <result pre="value âˆ’5.48), colon cancer cell lines (log GI50 value âˆ’5.51)," exact="central nervous system cancer" post="cell lines (log GI50 value âˆ’5.49), melanoma cell lines"/>
 <result pre="cancer cell lines (log GI50 value âˆ’5.51), central nervous system" exact="cancer" post="cell lines (log GI50 value âˆ’5.49), melanoma cell lines"/>
 <result pre="GI50 value âˆ’5.49), melanoma cell lines (log GI50 value âˆ’5.48)," exact="ovarian cancer" post="cell lines (log GI50 value âˆ’5.49), renal cancer cell"/>
 <result pre="value âˆ’5.49), melanoma cell lines (log GI50 value âˆ’5.48), ovarian" exact="cancer" post="cell lines (log GI50 value âˆ’5.49), renal cancer cell"/>
 <result pre="âˆ’5.48), ovarian cancer cell lines (log GI50 value âˆ’5.49), renal" exact="cancer" post="cell lines (log GI50 value âˆ’5.53), prostate cancer cell"/>
 <result pre="value âˆ’5.49), renal cancer cell lines (log GI50 value âˆ’5.53)," exact="prostate cancer" post="cell lines (log GI50 value âˆ’5.50) and breast cancer"/>
 <result pre="âˆ’5.49), renal cancer cell lines (log GI50 value âˆ’5.53), prostate" exact="cancer" post="cell lines (log GI50 value âˆ’5.50) and breast cancer"/>
 <result pre="âˆ’5.53), prostate cancer cell lines (log GI50 value âˆ’5.50) and" exact="breast cancer" post="cell lines (log GI50 value âˆ’5.56) in comparison with"/>
 <result pre="prostate cancer cell lines (log GI50 value âˆ’5.50) and breast" exact="cancer" post="cell lines (log GI50 value âˆ’5.56) in comparison with"/>
 <result pre="âˆ’5.93), non-small cell lung cell lines (log GI50 value âˆ’6.0)," exact="colon cancer" post="cell lines (log GI50 value âˆ’5.89), central nervous system"/>
 <result pre="non-small cell lung cell lines (log GI50 value âˆ’6.0), colon" exact="cancer" post="cell lines (log GI50 value âˆ’5.89), central nervous system"/>
 <result pre="value âˆ’6.0), colon cancer cell lines (log GI50 value âˆ’5.89)," exact="central nervous system cancer" post="cell lines (log GI50 value âˆ’5.73), melanoma cell lines"/>
 <result pre="cancer cell lines (log GI50 value âˆ’5.89), central nervous system" exact="cancer" post="cell lines (log GI50 value âˆ’5.73), melanoma cell lines"/>
 <result pre="GI50 value âˆ’5.73), melanoma cell lines (log GI50 value âˆ’5.89)," exact="ovarian cancer" post="cell lines (log GI50 value âˆ’5.74), renal cancer cell"/>
 <result pre="value âˆ’5.73), melanoma cell lines (log GI50 value âˆ’5.89), ovarian" exact="cancer" post="cell lines (log GI50 value âˆ’5.74), renal cancer cell"/>
 <result pre="âˆ’5.89), ovarian cancer cell lines (log GI50 value âˆ’5.74), renal" exact="cancer" post="cell lines (log GI50 value âˆ’5.90), prostate cancer cell"/>
 <result pre="value âˆ’5.74), renal cancer cell lines (log GI50 value âˆ’5.90)," exact="prostate cancer" post="cell lines (log GI50 value âˆ’5.72) and breast cancer"/>
 <result pre="âˆ’5.74), renal cancer cell lines (log GI50 value âˆ’5.90), prostate" exact="cancer" post="cell lines (log GI50 value âˆ’5.72) and breast cancer"/>
 <result pre="âˆ’5.90), prostate cancer cell lines (log GI50 value âˆ’5.72) and" exact="breast cancer" post="cell lines (log GI50 value âˆ’6.0) as compared with"/>
 <result pre="prostate cancer cell lines (log GI50 value âˆ’5.72) and breast" exact="cancer" post="cell lines (log GI50 value âˆ’6.0) as compared with"/>
 <result pre="were evaluated and appraised for anti-proliferative activities against sixty human" exact="cancer" post="cell lines. These chlorotrifluoromethyl phenyl ureido picolinamide benzothiazoles 7"/>
 <result pre="9 (Figure 5) were more potent in the treatment of" exact="renal cell carcinoma" post="than the standard drug sorafenib, used for the treatment"/>
 <result pre="The 3,5-bis-trifluoromethylphenylurea 8 showed good inhibitory activities against ACHN (renal" exact="cancer" post="cells lines) and A-498 (human kidney carcinoma cell line)"/>
 <result pre="lines, namely MDA-MB-231 (human breast adenocarcinoma cell line), MNK-45 (gastric" exact="cancer" post="cell line), NCI-H226 (human lung cancer cell line), HT-29"/>
 <result pre="adenocarcinoma cell line), MNK-45 (gastric cancer cell line), NCI-H226 (human" exact="lung cancer" post="cell line), HT-29 (human colorectal adenocarcinoma cell line) and"/>
 <result pre="cell line), MNK-45 (gastric cancer cell line), NCI-H226 (human lung" exact="cancer" post="cell line), HT-29 (human colorectal adenocarcinoma cell line) and"/>
 <result pre="reaction conditions and evaluated their anticancer activity against four different" exact="cancer" post="cell line such as human colon cancer cells (HT29),"/>
 <result pre="activity against four different cancer cell line such as human" exact="colon cancer" post="cells (HT29), human lung cancer cell (H460), non-small cell"/>
 <result pre="against four different cancer cell line such as human colon" exact="cancer" post="cells (HT29), human lung cancer cell (H460), non-small cell"/>
 <result pre="cell line such as human colon cancer cells (HT29), human" exact="lung cancer" post="cell (H460), non-small cell lung cancer (A549) and human"/>
 <result pre="line such as human colon cancer cells (HT29), human lung" exact="cancer" post="cell (H460), non-small cell lung cancer (A549) and human"/>
 <result pre="cancer cells (HT29), human lung cancer cell (H460), non-small cell" exact="lung cancer" post="(A549) and human breast cancer (MDA-MB-231). Among these derivatives,"/>
 <result pre="cells (HT29), human lung cancer cell (H460), non-small cell lung" exact="cancer" post="(A549) and human breast cancer (MDA-MB-231). Among these derivatives,"/>
 <result pre="cancer cell (H460), non-small cell lung cancer (A549) and human" exact="breast cancer" post="(MDA-MB-231). Among these derivatives, the indole based hydrazine carboxamide"/>
 <result pre="cell (H460), non-small cell lung cancer (A549) and human breast" exact="cancer" post="(MDA-MB-231). Among these derivatives, the indole based hydrazine carboxamide"/>
 <result pre="14 (N-(4-(benzo[d]thiazol-2-yl)phenyl)-2-(1-phenyl-1H-benzo[d]imidazol-2-yl-thio)-acetamide) (Figure 8) showed remarkable antitumor potential against different" exact="cancer" post="cell lines. The heterocylic substitutions affect the activity and"/>
 <result pre="lines, such as CCRF-SB (Human acute B-lymphoblastic leukaemia), DU-145 (human" exact="prostate cancer" post="cell lines express androgen receptor), HepG-2 cell line (human"/>
 <result pre="such as CCRF-SB (Human acute B-lymphoblastic leukaemia), DU-145 (human prostate" exact="cancer" post="cell lines express androgen receptor), HepG-2 cell line (human"/>
 <result pre="which incorporate piperazine moieties and evaluated their cytotoxicity against different" exact="cancer" post="cell lines such as HUH-7 (Heptacellular), MCF-7 (Breast) and"/>
 <result pre="derivatives. These novel derivatives were tested for anticancer potential against" exact="cancer" post="cell lines MCF-7 and HeLa cells. The MTT assay"/>
 <result pre="human fibroblasts and strong antiproliferative effects on MiaPaCa-2 and MCF-7" exact="cancer" post="cell lines. The experimental data indicated that the benzothiazole"/>
 <result pre="as SW480 (colon adenocarcinoma), HeLa, A549, HCT-116, HepG2 and SKRB-3" exact="breast cancer" post="cell line. The substituted bromopyridine acetamide benzothiazole derivative 29"/>
 <result pre="SW480 (colon adenocarcinoma), HeLa, A549, HCT-116, HepG2 and SKRB-3 breast" exact="cancer" post="cell line. The substituted bromopyridine acetamide benzothiazole derivative 29"/>
 <result pre="BTA scaffold 30 proved to be a promising candidate for" exact="cancer" post="chemotherapy37. Figure 18. Substituted pyridine based acetamide benzothiazole 30"/>
 <result pre="pyridopyrimidinones based BTA derivatives which were examined against four different" exact="cancer" post="cell lines such as ME-180, DU-145, MCF-7 and B-16."/>
 <result pre="interesting cytotoxicity with IC50 value of 4.01â€‰ÂµM against ME-180 (human" exact="cervical cancer" post="cell line)38. 2.9. Pyrazole based benzothiazole derivatives as anticancer"/>
 <result pre="cytotoxicity with IC50 value of 4.01â€‰ÂµM against ME-180 (human cervical" exact="cancer" post="cell line)38. 2.9. Pyrazole based benzothiazole derivatives as anticancer"/>
 <result pre="SAR explained that the maximum cytotoxicity of derivative 34 against" exact="colon cancer" post="cell line was due to the presence of methoxy"/>
 <result pre="explained that the maximum cytotoxicity of derivative 34 against colon" exact="cancer" post="cell line was due to the presence of methoxy"/>
 <result pre="anticancer activity with a good percentage of growth inhibition against" exact="lung cancer," post="breast cancer and renal cancer cell lines. The good"/>
 <result pre="with a good percentage of growth inhibition against lung cancer," exact="breast cancer" post="and renal cancer cell lines. The good anticancer activity"/>
 <result pre="a good percentage of growth inhibition against lung cancer, breast" exact="cancer" post="and renal cancer cell lines. The good anticancer activity"/>
 <result pre="of growth inhibition against lung cancer, breast cancer and renal" exact="cancer" post="cell lines. The good anticancer activity of derivative 35"/>
 <result pre="which have been studied for their anticancer activity against 6" exact="cancer" post="cell lines such as laryngeal carcinoma (Hep-2), breast carcinoma"/>
 <result pre="cervical carcinoma (HeLa), pancreatic carcinoma (MiaPaCa-2), colon carcinoma (SW 620)," exact="lung carcinoma" post="(H 460), and diploid fibroblasts (WI 38). Among them,"/>
 <result pre="benzothiazole derivative 36 (Figure 21) showed potent activity against all" exact="cancer" post="cell lines used in the study42. 2.11. Piperidine based"/>
 <result pre="desired derivatives and studied their anticancer activities against rat brain" exact="glioma" post="(carcinogenic C6) cell line, human lung adenocarcinoma epithelial (A549)"/>
 <result pre="and acetic anhydride and studied their anticancer activity against three" exact="cancer" post="cell lines MCF-7, HeLa and MG63 (human osteosarcoma) The"/>
 <result pre="evaluated 24 benzothiazole-2-thiol derivatives for antiproliferative activities against different human" exact="cancer" post="cell lines such as A549, HCT-116, SW620, SW480, MDA-MB-468,"/>
 <result pre="44 (Figure 26) showed potent hGSTP1-1 inhibitory activities, useful in" exact="cancer" post="chemotherapy. The SAR studies pinpointed that both these scaffold"/>
 <result pre="A3 adenosine receptors. The A3 receptor is overexpressed in different" exact="cancer" post="cell lines. The quinolone based derivative 48 (Figure 29)"/>
 <result pre="phenyl]-2-aryloxyacetamide derivatives for cytotoxicity and anticancer activity against sixty human" exact="cancer" post="cell lines derived from 9 neoplastic diseases, among which"/>
 <result pre="51 (Figure 31) showed good anticancer activity against 9 different" exact="cancer" post="cell lines having GI50 values in the range of"/>
 <result pre="The derivative 51 exhibited GI50 = 7.18â€‰Ã—â€‰10âˆ’8â€‰M against non-small cell" exact="lung cancer" post="(HOP-92). The SAR studies showed that the highest activity"/>
 <result pre="derivative 51 exhibited GI50 = 7.18â€‰Ã—â€‰10âˆ’8â€‰M against non-small cell lung" exact="cancer" post="(HOP-92). The SAR studies showed that the highest activity"/>
 <result pre="against ovarian, renal, prostate, leukaemia, melanoma, lung, colon, CNS and" exact="breast cancer" post="cell lines. The thioxothiazolidine acetamide benzothiazole 52 (Figure 32)"/>
 <result pre="ovarian, renal, prostate, leukaemia, melanoma, lung, colon, CNS and breast" exact="cancer" post="cell lines. The thioxothiazolidine acetamide benzothiazole 52 (Figure 32)"/>
 <result pre="to afford final product and studied their anticancer activities against" exact="breast cancer" post="(MCF7) and liver cancer (HEPG2) cell lines. Among all"/>
 <result pre="afford final product and studied their anticancer activities against breast" exact="cancer" post="(MCF7) and liver cancer (HEPG2) cell lines. Among all"/>
 <result pre="and studied their anticancer activities against breast cancer (MCF7) and" exact="liver cancer" post="(HEPG2) cell lines. Among all these derivatives, nitrobenzylidene containing"/>
 <result pre="studied their anticancer activities against breast cancer (MCF7) and liver" exact="cancer" post="(HEPG2) cell lines. Among all these derivatives, nitrobenzylidene containing"/>
 <result pre="semicarbazide benzothiazole 55 (Figure 34) exhibited anticancer activity against four" exact="cancer" post="cell lines such as HT-29, H460, A549 and MDA-MB-231."/>
 <result pre="benzothiazole 56 (Figure 34) exhibited interesting antitumor activity against 60" exact="cancer" post="cell lines. The average GI50 value for derivative 56"/>
 <result pre="58 (Figure 35) were reported for their anticancer activity against" exact="pancreatic cancer" post="cells having IC50 values of 27â€‰Â±â€‰0.24â€‰ÂµM for 57 and"/>
 <result pre="(Figure 35) were reported for their anticancer activity against pancreatic" exact="cancer" post="cells having IC50 values of 27â€‰Â±â€‰0.24â€‰ÂµM for 57 and"/>
 <result pre="specific derivatives which were tested for their anticancer activities against" exact="lung carcinoma" post="(A549) cell line. Derivatives 61 and derivative 62 (Figure"/>
 <result pre="containing BTA derivatives and studied their antitumor activities against human" exact="prostate cancer" post="cell lines. Nâ€²-formyl-2â€&quot;(5-nitrothiophen-2-yl)benzothiazole-6-carbohydrazide 65 (Figure 40) exhibited potent anticancer"/>
 <result pre="BTA derivatives and studied their antitumor activities against human prostate" exact="cancer" post="cell lines. Nâ€²-formyl-2â€&quot;(5-nitrothiophen-2-yl)benzothiazole-6-carbohydrazide 65 (Figure 40) exhibited potent anticancer"/>
 <result pre="DNA-intercalating naphthalimide-benzothiazole derivatives and evaluated their cytotoxicities against three different" exact="cancer" post="cell lines such as HT29, A549 and MCF-7. Among"/>
 <result pre="of 2-arylaminobenzothiazole-arylpropeonones and studied their cytotoxic activities against different human" exact="cancer" post="cell lines. Among all synthesised derivatives, substituted phenylamino based"/>
 <result pre="of the primary tumour, metastases and reducing the population of" exact="cancer" post="stem cells78. As a consequence, many CAIs belonging to"/>
 <result pre="of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in" exact="amyotrophic lateral sclerosis." post="Drugs1996;52:549â€&quot;63.8891467 6VenkateshP, PandeyaNS.Synthesis, characterisation and anti-inflammatory activity of some"/>
 <result pre="shows potent and selective Inhibitory activity against lung, colon, and" exact="breast cancer" post="cell lines. J Med Chem2006;49:179â€&quot;85.16392802 19BaffyG.Hepatocellular carcinoma in type"/>
 <result pre="potent and selective Inhibitory activity against lung, colon, and breast" exact="cancer" post="cell lines. J Med Chem2006;49:179â€&quot;85.16392802 19BaffyG.Hepatocellular carcinoma in type"/>
 <result pre="ZhangL, XiaY, et al.A novel benzothiazole derivative SKLB826 inhibits human" exact="hepatocellular carcinoma" post="growth via inducing G2/M phase arrest and apoptosis. RSC"/>
 <result pre="and their inÂ vitro anticancer effects and antioxidant activities against" exact="pancreatic cancer" post="cells. Anticancer Res2017;37:6381â€&quot;9.29061823 59CindricM, PericM, KraljM, et al.Antibacterial and"/>
 <result pre="their inÂ vitro anticancer effects and antioxidant activities against pancreatic" exact="cancer" post="cells. Anticancer Res2017;37:6381â€&quot;9.29061823 59CindricM, PericM, KraljM, et al.Antibacterial and"/>
 <result pre="preliminary investigation of anticanceractivity of novel benzothiazole derivatives against A549" exact="lung carcinoma" post="cell line. Turk J Biochem2017;42: 217â€&quot;24. 62OanhKTD, HaiVH, ParkHS,"/>
 <result pre="CharrisJ, CamachoJ, et al.N-Formyl-2-(5-nitrothiophen-2-yl)benzothiazole-6-carbohydrazide as a potential anti-tumour agent for" exact="prostate cancer" post="in experimental studies. J Pharm Pharmacol2013;65:411â€&quot;22.23356850 64RaoNS, NageshN, NayakLV,"/>
 <result pre="CamachoJ, et al.N-Formyl-2-(5-nitrothiophen-2-yl)benzothiazole-6-carbohydrazide as a potential anti-tumour agent for prostate" exact="cancer" post="in experimental studies. J Pharm Pharmacol2013;65:411â€&quot;22.23356850 64RaoNS, NageshN, NayakLV,"/>
</results>
